Hypotension at Hour Two: Rate, Food, or Dry Weight?

1. Stop or pause UF immediately. Symptomatic hypotension with cramping during active ultrafiltration points to intravascular volume depletion; continuing UF deepens the deficit while you investigate.

2. Position and protect. Trendelenburg or supine with legs elevated supports venous return. Keep the patient in bed; do not let him walk.

3. Rapid focused assessment before treating:

• Lung sounds, JVD, edema, and weight trend - is he truly dry or is this vasodepressor/cardiac?
• Cardiac rhythm and pulse quality - rule out arrhythmia.
• Glucose - nausea, diaphoresis, and confusion can be hypoglycemia.
• Temperature and access site - rule out sepsis or bleeding.
• Ask about chest pain, dyspnea, and stool color.

4. Notify the nephrologist and request orders for a normal saline bolus (commonly 100–250 mL) rather than oral fluids, because he is nauseated and aspiration risk is real.

5. Continue monitoring BP and symptoms every 5–15 minutes until stable; document the UF volume removed, the intervention, and the response.

The reasoning is that hypotension during dialysis is a syndrome with several causes, and the safest sequence is to remove the immediate stressor (UF), support perfusion, then distinguish volume from non-volume causes before deciding whether to resume.

• UF rate: 3.8 L over 4 hours is about 950 mL/h, or roughly 13.6 mL/kg/h. That is at or above the range associated with more intradialytic hypotension and cramps. This is a plausible primary driver. I would lengthen the session, lower the UF goal, or both, and consider UF profiling rather than a flat rate.
• Food intake: A large meal during treatment shifts blood to the splanchnic circulation and can drop BP. This is modifiable and low risk. I would ask him to eat before treatment or limit intake to a small snack.
• Antihypertensive timing: Both carvedilol and lisinopril taken 90 minutes before treatment peak during the session and blunt the compensatory response to volume removal. I would discuss with the nephrologist whether to hold or shift the dose, not change it independently.
• Dry weight: Three consecutive early terminations with low end-of-treatment BPs suggest the prescribed dry weight may be too low, but that is a hypothesis, not a conclusion. It needs reassessment using post-treatment weight, BP, symptoms, and volume exam.
• Sodium modeling: It can reduce osmotic shifts and symptoms, but it does not fix an excessive UF rate and can increase thirst and interdialytic gain. It is an adjunct, not a substitute for accurate dry weight and a tolerable UF rate.

Priority: correct the UF rate and meal timing first; escalate dry-weight reassessment to the nephrologist.

Distinguishing the two:

• If the problem is UF rate, symptoms appear mid-treatment, BP recovers with fluid and UF reduction, and the patient tolerates the same total volume when it is removed more slowly.
• If the problem is dry weight too low, the patient is symptomatic near the end of treatment or repeatedly reaches a post-treatment weight below the prescribed dry weight, with flat or low BP, poor appetite, muscle wasting, or orthostatic symptoms between sessions.
• If the problem is neither - for example, cardiac dysfunction or autonomic neuropathy - BP falls early even at modest UF rates.

Data to collect:

• Pre- and post-treatment weights at every session, plus home weights.
• BP before, hourly during, and after treatment, with symptoms recorded.
• Actual UF rate and total volume removed versus goal.
• Volume exam findings: lung sounds, edema, JVD.
• Appetite, oral intake, and nutritional indicators.
• Any bioimpedance or other volume assessment the unit uses.

Practical test: plan a two-week trial with a lower UF rate and longer or additional time, then compare symptom frequency and end-of-treatment BP. A clear improvement supports rate as the driver; persistent symptoms at low rates support reassessing dry weight or cardiac status. Share the trend with the nephrologist rather than changing dry weight unilaterally.